Dr. Deshpande is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 York St
New Haven, CT 06510Phone+1 203-200-4822Fax+1 203-200-2099- Is this information wrong?
Education & Training
- Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1993 - 1995
- Jacobi Medical Center/Albert Einstein College of MedicineInternship, Internal Medicine, 1992 - 1993
- University of Leeds School of MedicineClass of 1991
Certifications & Licensure
- CT State Medical License 2001 - 2025
- NV State Medical License 2000 - 2003
- NY State Medical License 2001 - 2003
- AZ State Medical License 1998 - 2002
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- David Fischer Teaching Award Yale Cancer Center
Clinical Trials
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma Start of enrollment: 2007 Mar 01
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers Start of enrollment: 2007 May 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.Schuetze, S., Ballman, K., Heise, R., Ganjoo, K., Davis, E., George, S., Burgess, M., Choy, E., Shepard, D., Tinoco, G., Hirbe, A., Kelly, C., Attia, S., Deshpande, H....> ;Clinical Cancer Research. 2024 Mar 6
- 1 citationsClinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.Amin H Nassar, Edward El-Am, Ryan Denu, Sarah Abou Alaiwi, Talal El Zarif, Walid Macaron, Noha Abdel-Wahab, Aakash Desai, Caleb Smith, Kaushal Parikh, Muhannad Abbasi,...> ;JACC. Cardiooncology. 2024 Feb 1
- Neurogenic orthostatic hypotension after treatment with sorafenib.Catherine Wegner Wippel, Hari Deshpande, Huned Patwa, Aldo J Peixoto> ;BMJ Case Reports. 2022 Dec 22
- Join now to see all
Press Mentions
- Yale Cancer Center Shares Five Things You Need to Know About Sarcoma, a Rare CancerJuly 7th, 2021
- New Haven Company's 'Orphan Drug' May Aid Fight Against Rare CancerFebruary 8th, 2021
- Connecticut Gets Slight Boost in Vaccine Supply, but Distributors Say They Need More DosesJanuary 28th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: